By Jacqueline Howard, CNN
“Now a new study, presented at the American Society for Clinical Oncology’s annual meeting in Chicago on Sunday, describes a treatment approach specifically for patients with metastatic pancreatic cancer who had a BRCA1 or BRCA2 mutation.”
THN 